Genpharmasec Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Genpharmasec Ltd. on BSE

Load latest

Genpharmasec Ltd.

10 Feb 2023

2.00

-2.91%

Result

Genpharmasec Ltd - 531592 - Results- Financial Results For The Quarter Ended December''2022

BSE India

Pursuant to the provisions of Regulation 30 (2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good self that the Board of Directors of our Company in their meeting held on Friday, 10th February, 2023 has: 1. Considered and Approved and taken on records the Un-Audited Financial Results along with Limited Review Report for the Quarter and Nine months ended 31st December, 2022 prepared in terms of IND-AS, pursuant to Regulation 33 of (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Genpharmasec Ltd.

02 Feb 2023

2.00

-2.91%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Board Meeting To Be Held On Friday, …

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve We wish to inform your good self that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of our Company will be held on Friday, 10th February, 2023 at 03.00 P.M at its Registered Office, to inter-alia, 1. To Consider & approve the Un-Audited Financial Results along with the Limited Review Report for the Quarter ended on December 31, 2022 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. To confirm Closure of trading window from 01st January, 2023 till the end of 48 hours after the results are made public (both days inclusive) as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 for Directors and Designated Employees as defined in the "Code of Conduct for Prevention of Insider Trading of the Company. 3. Any other business matter with the permission of the Chair.

pdf

Genpharmasec Ltd.

31 Jan 2023

2.00

-2.91%

AGM

Genpharmasec Ltd - 531592 - Voting Results For Postal Ballot (Voting By Electronic Means) And Scrutinizer …

BSE India

This is in continuation to our letter dated December 28, 2022 regarding submission of Postal Ballot Notice seeking approval of Shareholders of the company by way of Special Resolution for: Appointment of Mr. Sachin Aphandkar (DIN: 08715329), as the Non-Executive Independent Director. Appointment of Mr. Mayur Bhatt (DIN: 08715614), as the Non-Executive Independent Director. Appointment of Mr. Siddhesh Shende (DIN: 09629926), as the Non-Executive Independent Director. The above resolution was placed through Postal Ballot and was passed with requisite Majority and deemed to be passed within a period of e- voting i.e. 31st December, 2022 till 29th January, 2023. In this regard, please find enclosed herewith: 1. Details of voting results of the Postal Ballot conducted through electronic means in the prescribed format pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Scrutinizer''s Report dated 30th January, 2023.

pdf

Genpharmasec Ltd.

17 Jan 2023

2.00

-2.91%

Company Update

Genpharmasec Ltd - 531592 - Providing Missed Information Of 2 Independent Director Who Had Resigned On …

BSE India

This is to inform you that on 21st June 2022, two Independent Directors had resigned owing to their personal reasons and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we intimated the Exchange about their resignations within the stipulated time. However, in the disclosure as required under Regulation 30(6) read with part A of schedule III of SEBI (LODR) Regulations, 2015 accompanying our intimation to BSE, the erstwhile Company Secretary inadvertently omitted to mention the holding position as Directors in any other listed entities. Therefore, as advised and instructed by the Exchange, we are once again intimating to the exchange about NIL applicability of Directorship in any other listed entities of 2 (two) Independent Directors namely, Mr. Yogesh Bhuva and Ms. Nikhita Pais on 22nd June 2022.

pdf

Genpharmasec Ltd.

06 Jan 2023

2.00

-2.91%

Company Update

Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants), Regulations, 2018, we are enclosing herewith a copy of certificate dated 2nd January, 2023 received from our Registrar & Share Transfer Agent (RTA) i.e. Satellite Corporate Services Pvt. Ltd. stating that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the respective depository has been substituted in the records as the registered owner within the stipulated time of receipt of certificate of security and they have complied with all the regulations and no other physical certificates are received for demat during the quarter ended 31st December, 2022.

pdf

Genpharmasec Ltd.

30 Dec 2022

2.00

-2.91%

Company Update

Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we herewith enclose Newspaper publication of Postal Ballot Notice which was published on 29.12.2022.

pdf

Genpharmasec Ltd.

30 Dec 2022

2.00

-2.91%

SAST

Genpharmasec Ltd - 531592 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and BSE Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019. The Trading Window for trading and/ or dealing in the securities of the Company shall remain closed for all Designated & Connected Persons with effect from 02nd January, 2023 till the end of 48 hours after declaration of financial results for the quarter ended 31st December, 2022. The date of Board Meeting for consideration and declaration of the Financial Results for the quarter ended 31st December, 2022 shall be intimated to you separately.

pdf

Genpharmasec Ltd.

28 Dec 2022

2.00

-2.91%

Company Update

Genpharmasec Ltd - 531592 - Notice Of Postal Ballot And E-Voting

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of Postal Ballot and E-Voting together with Explanatory Statement sent to the members of the Company whose names appeared on the Register of Members/ List of Beneficial Owners as on Friday, 23rd December 2022 i.e. Cut-off date

pdf

Genpharmasec Ltd.

28 Dec 2022

2.00

-2.91%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, …

BSE India

Pursuant to the provisions of Regulation 30 (2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform your good self that the Board of Directors of our Company in their meeting held on Wednesday, 28th December, 2022 has: 1. Approved Notice of Postal Ballot and E-Voting. 2. Approved the Calendar of events for Postal Ballot and E-Voting. 3. Approved the appointment of Scruntinizer. 4. Approved and fixed 23rd December, 2022 as the CUT-OFF DATE for the purpose of reckoning the Voting rights of members in the Postal Ballot and E-Voting process of the Company.

pdf

Genpharmasec Ltd.

20 Dec 2022

2.00

-2.91%

Board Meeting

Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held …

BSE India

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/12/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of our Company will be held on Wednesday, 28th December, 2022 at 10.00 A.M. at its Registered Office, to inter-alia, 1. To consider and approve the Notice for Postal Ballot for the appointment of two new Independent Directors under Regulation 17(1C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. To consider and approve the Calendar of events for Postal Ballot. 3. To consider and approve the appointment of Mr. Jaymin Modi, Practicing Company Secretary to act as Scrutinizer for E-voting at ensuing Postal Ballot Meeting. 4. To take on records Company has fixed 23rd December, 2022 as the CUT-OFF DATE to ascertain the eligibility of the members of the Company to cast their votes for Postal Ballot of the Company. 5. Any other business matter with the permission of the Chair.

pdf

Is Generic Pharmasec Ltd. worth buying?

105 Votes:

Buy 83.81%

Sell 6.67%

Hold 9.52%